Determination of optimum vitamin D3 levels for NK cell-mediated rituximab- and obinutuzumab-dependent cellular cytotoxicity.

Neumann, Frank

Determination of optimum vitamin D3 levels for NK cell-mediated rituximab- and obinutuzumab-dependent cellular cytotoxicity. [electronic resource] - Cancer immunology, immunotherapy : CII Nov 2018 - 1709-1718 p. digital

Publication Type: Journal Article

1432-0851

10.1007/s00262-018-2224-y doi


Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized--pharmacology
Antibody-Dependent Cell Cytotoxicity--immunology
Antineoplastic Agents, Immunological--pharmacology
Case-Control Studies
Cholecalciferol--blood
Cytotoxicity, Immunologic--immunology
Female
Healthy Volunteers
Humans
Killer Cells, Natural--immunology
Lymphocyte Activation
Lymphoma, Large B-Cell, Diffuse--blood
Male
Middle Aged
Rituximab--pharmacology